Genetic Signatures Ltd ABN 30 095 913 205 7 Eliza Street, Newtown NSW 2042 Telephone + 612 9870 7580 Email: investors@geneticsignatures.com ASX Announcement 8 October 2026 Quarterly Activities Report and Appendix 4C HIGHLIGHTS • Genetic Signatures closed Q1 FY2027 with $20.9 million in cash...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 9 pages · English
Summary by 6ix AI
Genetic Signatures Ltd. has released its quarterly activities report and cash flow statement for the first quarter of the fiscal year, detailing operational updates and financial performance. The company reported a significant reduction in net operating cash outflow compared to previous quarters, reflecting effective cost management and restructuring efforts. Sales for the quarter were recorded at a notable amount, with receipts from customers also showing a positive trend.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings CallRelease
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- GSS Investor Presentation - Proposed Merger with MAP
- Receipt of Section 249D Notice from BCAL Diagnostics
- BDX Holdings of GSS Shares and receipt of Section 249D
- Genetic Signatures and Microba in Merger Discussions
- FY26 Market Update
Later from Genetic Signatures
- GSS: Response to Media Speculation & BCAL letter to GSS
- Response to Media Speculation & BCAL letter to GSS
- Update on Commercial Terms for Proposed Merger with MAP
- Addendum to Notice of Annual General Meeting
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures